Regulatory approval of COVID-19 Vaccine Janssen, MHRA (updated 12th May 2022)
Information for healthcare professionals and the public about the COVID-19 Vaccine Janssen
12 May 2022Updated SPC and PIL: SPC - Under " Special Warnings " section, " Guillain-Barr é syndrome " section updated to include transverse myelitis. PIL - Added info on Neurological disorders - Inflamation of the spinal corrd (transverse myelitis) PIL - Added inflamation of the spinal cord to " Possible side effects " section, under " unknown " heading.
14 February 2022Updated product information for HTML links to Summary of product characteristics and patient information leaflet. The changes are also included in the PDF attachments.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: Brain | Covid Vaccine | COVID-19 | Guillain-Barr Syndrome | Health | Neurology | Vaccines | Warnings